Anuh Pharma Limited

Company Profile

Anuh Pharma Limited had its IPO on under the ticker symbol 506260.

The company operates in the Healthcare sector and Drugs - Generic industry. Anuh Pharma Limited has a staff strength of 147 employees.

Stock update

Shares of Anuh Pharma Limited opened at ₹131.5 at the start of the last trading session i.e. 2023-09-13.

The stocks traded within a range of ₹128 - ₹133.85, and closed at ₹128.65.

This is a -3.09% slip from the previous day's closing price.

A total volume of 48,708 shares were traded at the close of the day’s session.

In the last one week, shares of Anuh Pharma Limited have slipped by -5.54%.

Anuh Pharma Limited's Key Ratios

Anuh Pharma Limited has a market cap of ₹8.38 billion, indicating a price to book ratio of 4.0412 and a price to sales ratio of 1.9491.

In the last 12-months Anuh Pharma Limited’s revenue was ₹3.89 billion with a gross profit of ₹737.38 million and an EBITDA of ₹629.97 million. The EBITDA ratio measures Anuh Pharma Limited's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Anuh Pharma Limited’s operating margin was 11.25% while its return on assets stood at 8.77% with a return of equity of 16.42%.

In Q3, Anuh Pharma Limited’s quarterly earnings growth was a positive 120% while revenue growth was a positive 55.9%.

Anuh Pharma Limited’s PE and PEG Ratio

Forward PE

0

Trailing PE

26.04

PEG

Its diluted EPS in the last 12-months stands at ₹5.747 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Anuh Pharma Limited’s profitability.

Anuh Pharma Limited stock is trading at a EV to sales ratio of 1.8559 and a EV to EBITDA ratio of 13.4175. Its price to sales ratio in the trailing 12-months stood at 1.9491.

Anuh Pharma Limited stock pays annual dividends of ₹2.75 per share, indicating a yield of 1.84% and a payout ratio of 23.94%.

Balance sheet and cash flow metrics

Total Assets

₹4.05 billion

Total Liabilities

₹1.61 billion

Operating Cash Flow

₹-434837000.00

Capital Expenditure

₹15.50 million

Dividend Payout Ratio

23.94%

Anuh Pharma Limited ended 2024 with ₹4.05 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹4.05 billion while shareholder equity stood at ₹2.41 billion.

Anuh Pharma Limited ended 2024 with ₹0 in deferred long-term liabilities, ₹1.61 billion in other current liabilities, 250560000.00 in common stock, ₹2.16 billion in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹19.27 million and cash and short-term investments were ₹579.04 million. The company’s total short-term debt was ₹0 while long-term debt stood at ₹0.

Anuh Pharma Limited’s total current assets stands at ₹3.08 billion while long-term investments were ₹0 and short-term investments were ₹512.53 million. Its net receivables were ₹1.71 billion compared to accounts payable of ₹0 and inventory worth ₹726.36 million.

In 2024, Anuh Pharma Limited's operating cash flow was ₹-434837000.00 while its capital expenditure stood at ₹15.50 million.

Comparatively, Anuh Pharma Limited paid ₹0.24 in dividends in 2024.

Other key metrics

Current Trading Price

₹128.65

52-Week High

₹140.5

52-Week Low

₹75.8346

Analyst Target Price

₹

Anuh Pharma Limited stock is currently trading at ₹128.65 per share. It touched a 52-week high of ₹140.5 and a 52-week low of ₹140.5. Analysts tracking the stock have a 12-month average target price of ₹.

Its 50-day moving average was ₹121.44 and 200-day moving average was ₹96.97 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 6853.5% of the company’s stock are held by insiders while 0% are held by institutions.